arrow
C

Clinton F. Stewart

pharmacy and pharmaceutical sciences
H指数:76
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Model-Informed Early Prediction of Methotrexate-Induced Acute Kidney Injury in Pediatric Patients with Osteosarcoma Using Real-World Data: A Multi-center Pharmacokinetic Study

基于真实世界数据的儿童骨肉瘤患者甲氨蝶呤诱导急性肾损伤的模型化早期预测:一项多中心药代动力学研究

2026-06-040
PRE
Targeting the p53 pathway to treat atypical teratoid rhabdoid tumors

靶向p53通路治疗非典型性横纹肌样瘤

2026-01-010
PRE
Molecular insights into response and resistance in children with relapsed/refractory brain tumors on ribociclib combination therapy: results from SJDAWN

关于接受ribociclib联合疗法治疗的复发/难治性脑瘤患儿的应答与耐药性的分子机制研究:SJDAWN研究的结果

2025-11-010
OAAI
Comparison of GFR estimation equations using creatinine, cystatin C, and their combination in pediatric hematology-oncology: no single equation is superior across subgroups

使用肌酐、胱抑素C及其组合估算GFR方程在儿科血液肿瘤学中的比较:没有单一方程在所有亚组中均具有优势

2025-04-230
PRE
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4

一项关于selumetinib治疗复发性/进展性儿童低级别胶质瘤的PBTC二期研究:Strata 2、5和6,以及Strata 1、3和4的长期结局。

2025-04-170
PRE
MOLECULAR AND BIOLOGY CORRELATIVE RESULTS FROM THE PHASE 1B TRIAL OF UNESBULIN (PTC596) WITH RADIOTHERAPY IN CHILDREN NEWLY-DIAGNOSED WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)
2024-11-110
PRE
REPORT ON PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-029B, A PROSPECTIVE PHASE 2 CLINICAL TRIAL OF SELUMETINIB IN TREATING YOUNG PATIENTS WITH RECURRENT/PROGRESSIVE LOW-GRADE GLIOMA: NEW RESULTS ON STRATA 2, 5, AND 6 WITH UPDATED LONG-TERM SURVIVAL OUTCOMES ON STRATA 1, 3, AND 4
2024-06-180
OAAI
PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC)-056: A PHASE 1 STUDY OF THE ADAM-10 INHIBITOR, INCB007839, IN CHILDREN WITH RECURRENT/PROGRESSIVE HIGH-GRADE GLIOMAS TO TARGET MICROENVIRONMENTAL NEUROLOGIN-3
2024-06-180
OAAI
RESULTS FROM SJDAWN: A ST JUDE CHILDREN'S RESEARCH HOSPITAL PHASE 1 STUDY EVALUATING MOLECULARLY DRIVEN DOUBLET THERAPIES FOR ALL CHILDREN WITH REFRACTORY OR RECURRENT CENTRAL NERVOUS SYSTEM (CNS) MALIGNANT NEOPLASMS AND YOUNG ADULTS WITH SHH MEDULLOBLASTOMA
2024-06-180
OAAI
A PHASE 1 STUDY OF SAVOLITINIB IN RECURRENT, PROGRESSIVE, OR REFRACTORY MEDULLOBLASTOMA, HIGH-GRADE GLIOMA, DIFFUSE INTRINSIC PONTINE GLIOMA, AND CENTRAL NERVOUS SYSTEM (CNS) TUMORS HARBORING MET ABERRATIONS: A PEDIATRIC BRAIN TUMOR CONSORTIUM TRIAL
2023-06-120
OAAI
UPDATED FINDINGS FROM THE PHASE IB STUDY OF UNESBULIN (PTC596) IN CHILDREN WITH NEWLY-DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)

新诊断的弥漫性内在性脑桥胶质瘤 (DIPG) 和高级别胶质瘤 (HGG) 儿童UNESBULIN (PTC596) IB期研究的最新发现: 来自神经肿瘤学临床试验合作网络 (CONNECT) 的报告

2023-06-120
OAAI
Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors

小儿中枢神经系统肿瘤颅脊髓照射后认知功能下降的遗传易感性

2023-04-111
PRE